Iron sucrose complex drugs - identical or just similar?

Continuing the series of HPE Pharmacist Roundtable Meetings on complex non-biological drugs, a panel of senior European hospital pharmacists and renal specialists met in Utrecht, The Netherlands, to discuss insights and advances in the field and to consider the evidence for therapeutic differences between iron sucrose originator and iron sucrose similar preparations.

 

Click here to read the full report

 

Regulation of complex molecules 

Roundtable meetings in London and Paris discussed evidence for therapeutic differences between the originator iron sucrose and iron sucrose similars and called for a new regulatory pathway for non-biological complex molecules.

 

Click here to read the full report

Theoretical understanding of multiple sclerosis remains a challenge to scientists and clinicians. 
The HPE Multiple Sclerosis Supplement explores the latest insights into the biochemistry of the   
condition and the evolving developments in care pathways and drug treatments.